About 400 MG Daratumumab Concentrate For Solution For Infusion
Highlighted as an illustrious choice in oncology, 400 MG Daratumumab Concentrate For Solution For Infusion stands out for adult patients with multiple myeloma. Delivered via intravenous infusion, this single-use, preservative-free vial offers unbeatable purity and stability. Select medical centers across India have remarked on its consistent efficacy and manageable administration timeframes. The product must be diluted with 0.9% sodium chloride before use and displays compatibility with both PVC and polyolefin bags. Savings in storage efficiency and reliability underscore its remarkable position among similar therapies. Prescription-only.
Daratumumab 400mg: Diverse Applications for Multiple Myeloma
This 400 MG Daratumumab solution is specifically developed for use in treating adult patients with multiple myeloma. The product finds its application in hematology clinics, specialized oncology centers, and tertiary care hospitals. Used exclusively for intravenous infusions after dilution, it is suited for initial lengthy infusions, as well as shorter repeat administrations as patients tolerate. Its compatibility, stability, and trusted formulation make it a vital addition for practitioners managing multiple myeloma cases.
Efficient Procurement: Payment, Delivery & Sample Logistics
Flexible payment terms accommodate the needs of various healthcare facilities and traders. Our logistics ensure quick dispatch and dependable delivery, with express shipping available on request to guarantee timely arrivals. Each order is handled with meticulous care across India, and sample vials can be arranged for evaluation. You can rely on streamlined processes and robust logistics to support your procurement needs, ensuring seamless delivery of this essential oncology medication.
FAQ's of 400 MG Daratumumab Concentrate For Solution For Infusion:
Q: How should 400 MG Daratumumab Concentrate be administered?
A: Daratumumab is administered via intravenous infusion only, after dilution with 0.9% sodium chloride. The initial infusion takes approximately 7 hours, with shorter durations for subsequent infusions as tolerated.
Q: What advantages does Daratumumab offer for multiple myeloma patients?
A: Daratumumab is a monoclonal antibody highlighted for its effectiveness in treating adult patients with multiple myeloma, offering improved response rates and overall management in combination with established therapies.
Q: Where should the concentrate be stored to maintain its quality?
A: The unopened vial should be stored refrigerated at 2C to 8C. It must not be frozen and should be kept within its shelf life of 24 months for optimal potency.
Q: What is the process for ordering Daratumumab from India?
A: To place an order, contact us directly to discuss payment terms and shipment options. We provide quick dispatch and express shipping for both bulk and smaller quantities, with sample vials available if required.
Q: When is pre-medication recommended during treatment?
A: Pre-medication is advised before each infusion to minimize the risk of infusion-related reactions, which are a known complication during daratumumab therapy.
Q: Is this product compatible with standard infusion equipment?
A: Yes, Daratumumab concentrate is compatible with both PVC and polyolefin infusion bags, making it versatile for use in most hematology and oncology settings.